Genome editing in clinical genetics: points to consider-a statement of the American College of Medical Genetics and Genomics

被引:13
|
作者
Watson, Michael S. [1 ]
机构
[1] Amer Coll Med Genet & Genom, Bethesda, MD USA
关键词
biotechnology; CRISPR/Cas9; gene editing; genetic engineering; gene drives;
D O I
10.1038/gim.2016.195
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Disclaimer: These recommendations are designed primarily as an educational resource for medical geneticists and other health-care providers, to help them provide quality medical genetic services. Adherence to these recommendations does not necessarily assure a successful medical outcome. These recommendations should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. In determining the propriety of any specific procedure or test, the geneticist should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen. It may be prudent, however, to document in the patient's record the rationale for any significant deviation from these recommendations.
引用
收藏
页码:723 / 724
页数:2
相关论文
共 50 条
  • [1] Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG)
    Bush, Lynn W.
    Bartoshesky, Louis E.
    David, Karen L.
    Wilfond, Benjamin
    Williams, Janet L.
    Holm, Ingrid A.
    GENETICS IN MEDICINE, 2018, 20 (07) : 692 - 694
  • [2] The clinical application of polygenic risk scores: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
    Abu-El-Haija, Aya
    V. Reddi, Honey
    Wand, Hannah
    Rose, Nancy C.
    Mori, Mari
    Qian, Emily
    Murray, Michael F.
    GENETICS IN MEDICINE, 2023, 25 (05)
  • [3] Points to consider for providing expert witness testimony for the specialty of medical genetics: A statement of the American College of Medical Genetics and Genomics (ACMG)
    Seaver, Laurie H.
    Chan, Perry
    Fleisher, Lynn D.
    Huang, Samuel J.
    Klugman, Susan D.
    Matalon, Dena R.
    GENETICS IN MEDICINE, 2024, 26 (10)
  • [4] ACMG STATEMENT Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
    Matalon, Dena R.
    Zepeda-Mendoza, Cinthya J.
    Aarabi, Mahmoud
    Brown, Kaitlyn
    Fullerton, Stephanie M.
    Kaur, Shagun
    Quintero-Rivera, Fabiola
    Vatta, Matteo
    GENETICS IN MEDICINE, 2023, 25 (06)
  • [5] Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG)
    David, Karen L.
    Best, Robert G.
    Brenman, Leslie Manace
    Bush, Lynn
    Deignan, Joshua L.
    Flannery, David
    Hoffman, Jodi D.
    Holm, Ingrid
    Miller, David T.
    O'Leary, James
    Pyeritz, Reed E.
    GENETICS IN MEDICINE, 2019, 21 (04) : 769 - 771
  • [6] Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG)
    Alkuraya, Fowzan S.
    Gray, Kathryn J.
    Prakash, Siddharth K.
    Wojcik, Monica H.
    Lin, Angela E.
    GENETICS IN MEDICINE, 2023, 25 (10)
  • [7] Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG)
    Deignan, Joshua L.
    De Castro, Mauricio
    Horner, Vanessa L.
    Johnston, Tami
    Macaya, Daniela
    Maleszewski, Joseph J.
    Reddi, Honey, V
    Tayeh, Marwan K.
    GENETICS IN MEDICINE, 2023, 25 (05)
  • [8] ACMG STATEMENT Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
    Pena, Loren D. M.
    Burrage, Lindsay C.
    Enns, Gregory M.
    Esplin, Edward D.
    Harding, Cary
    Mendell, Jerry R.
    Niu, Zhiyv
    Scharfe, Curt
    Yu, Timothy
    Koeberl, Dwight D.
    GENETICS IN MEDICINE, 2023, 25 (06)
  • [9] The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
    Tayeh, Marwan K.
    Chen, Margaret
    Fullerton, Stephanie M.
    Gonzales, Patrick R.
    Huang, Samuel J.
    Massingham, Lauren J.
    O'Daniel, Julianne M.
    Stewart, Douglas R.
    Stiles, Ashlee R.
    Evans, Barbara J.
    GENETICS IN MEDICINE, 2023, 25 (03)
  • [10] Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
    Grebe, Theresa A.
    Khushf, George
    Greally, John M.
    Turley, Patrick
    Foyouzi, Nastaran
    Rabin-Havt, Sara
    Berkman, Benjamin E.
    Pope, Kathleen
    Vatta, Matteo
    Kaur, Shagun
    GENETICS IN MEDICINE, 2024, 26 (04)